Lifetime risk of common neurological diseases in the elderly population
- PMID: 30279211
- DOI: 10.1136/jnnp-2018-318650
Lifetime risk of common neurological diseases in the elderly population
Abstract
Objective: To quantify the burden of common neurological disease in older adults in terms of lifetime risks, including their co-occurrence and preventive potential, within a competing risk framework.
Methods: Within the prospective population-based Rotterdam Study, we studied lifetime risk of dementia, stroke and parkinsonism between 1990 and 2016. Among 12 102 individuals (57.7% women) aged ≥45 years free from these diseases at baseline, we studied co-occurrence, and quantified the combined, and disease-specific remaining lifetime risk of these diseases at various ages for men and women separately. We also projected effects on lifetime risk of hypothetical preventive strategies that delay disease onset by 1, 2 and 3 years, respectively.
Results: During follow-up of up to 26 years (156 088 person-years of follow-up), 1489 individuals were diagnosed with dementia, 1285 with stroke and 263 with parkinsonism. Of these individuals, 438 (14.6%) were diagnosed with multiple diseases. Women were almost twice as likely as men to be diagnosed with both stroke and dementia during their lifetime. The lifetime risk for any of these diseases at age 45 was 48.2% (95% CI 47.1% to 51.5%) in women and 36.2% (35.1% to 39.3%) in men. This difference was driven by a higher risk of dementia as the first manifesting disease in women than in men (25.9% vs 13.7%; p<0.001), while this was similar for stroke (19.0%vs18.9% in men) and parkinsonism (3.3% vs 3.6% in men). Preventive strategies that delay disease onset with 1 to 3 years could theoretically reduce lifetime risk for developing any of these diseases by 20%-50%.
Conclusion: One in two women and one in three men will develop dementia, stroke or parkinsonism during their life. These findings strengthen the call for prioritising the focus on preventive interventions at population level which could substantially reduce the burden of common neurological diseases in the ageing population.
Keywords: dementia; stroke.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.PLoS Med. 2019 Feb 4;16(2):e1002741. doi: 10.1371/journal.pmed.1002741. eCollection 2019 Feb. PLoS Med. 2019. PMID: 30716101 Free PMC article.
-
Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248. JAMA Neurol. 2017. PMID: 28973176 Free PMC article.
-
Life expectancy of parkinsonism patients in the general population.Parkinsonism Relat Disord. 2020 Aug;77:94-99. doi: 10.1016/j.parkreldis.2020.06.018. Epub 2020 Jun 24. Parkinsonism Relat Disord. 2020. PMID: 32712564
-
Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study.Lancet Neurol. 2007 Dec;6(12):1106-14. doi: 10.1016/S1474-4422(07)70291-0. Lancet Neurol. 2007. PMID: 18031707 Review.
-
Depression, stroke, and dementia in patients with myocardial infarction.Dan Med J. 2018 Apr;65(4):B5423. Dan Med J. 2018. PMID: 29619929 Review.
Cited by
-
Chronic stroke survivors underestimate their upper limb motor ability in a simple 2D motor task.J Neuroeng Rehabil. 2024 Oct 1;21(1):175. doi: 10.1186/s12984-024-01471-1. J Neuroeng Rehabil. 2024. PMID: 39354594 Free PMC article.
-
Multimorbidity patterns and the association with health status of the oldest-old in long-term care facilities in China: a two-step analysis.BMC Geriatr. 2023 Dec 13;23(1):851. doi: 10.1186/s12877-023-04507-8. BMC Geriatr. 2023. PMID: 38093203 Free PMC article.
-
Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms.Molecules. 2023 Dec 4;28(23):7935. doi: 10.3390/molecules28237935. Molecules. 2023. PMID: 38067664 Free PMC article. Review.
-
Impact of interventions scenarios targeting three main vascular risk factors on the future burden of dementia in France.Eur J Epidemiol. 2023 Apr;38(4):435-443. doi: 10.1007/s10654-023-00974-w. Epub 2023 Feb 28. Eur J Epidemiol. 2023. PMID: 36853527
-
Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.Mov Disord. 2023 Mar;38(3):489-495. doi: 10.1002/mds.29314. Epub 2023 Jan 4. Mov Disord. 2023. PMID: 36598340 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous